Fusion Antibodies plc (FAB.L)

GBp 6.55

(0.77%)

Operating Income Summary of Fusion Antibodies plc

Fusion Antibodies plc's latest annual operating income in 2023 was -2.28 Million GBP , up 19.1% from previous year.
Fusion Antibodies plc's latest quarterly operating income in 2023 FY was -2.29 Million GBP , up 19.1% from previous quarter.
Fusion Antibodies plc reported an annual operating income of -2.83 Million GBP in 2022, down -112.69% from previous year.
Fusion Antibodies plc reported an annual operating income of -1.33 Million GBP in 2021, up 3.41% from previous year.
Fusion Antibodies plc reported a quarterly operating income of -1.41 Million GBP for 2023 Q2, down 0.0% from previous quarter.
Fusion Antibodies plc reported a quarterly operating income of -873 Thousand GBP for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Fusion Antibodies plc (2023 - 2012)

Historical Annual Operating Income of Fusion Antibodies plc (2023 - 2012)

Year	Operating Income	Operating Income Growth
2023	-2.28 Million GBP	19.1%
2022	-2.83 Million GBP	-112.69%
2021	-1.33 Million GBP	3.41%
2020	-1.37 Million GBP	-23.79%
2019	-1.11 Million GBP	26.15%
2018	-1.5 Million GBP	-2517.63%
2017	62.39 Thousand GBP	-50.69%
2016	126.53 Thousand GBP	357.03%
2015	27.68 Thousand GBP	128.02%
2014	-98.78 Thousand GBP	17.28%
2013	-119.42 Thousand GBP	74.76%
2012	-473.21 Thousand GBP	0.0%

Year	Operating Income	Operating Income Growth
2023 FY	-2.29 Million GBP	19.1%
2023 Q2	-1.41 Million GBP	0.0%
2023 Q4	-873 Thousand GBP	0.0%
2022 Q4	-1.6 Million GBP	0.0%
2022 FY	-2.83 Million GBP	-112.69%
2022 Q2	-1.26 Million GBP	0.0%
2021 FY	-1.33 Million GBP	3.41%
2021 Q4	-660 Thousand GBP	0.0%
2021 Q2	-695 Thousand GBP	0.0%
2020 Q2	-606 Thousand GBP	0.0%
2020 Q4	-837 Thousand GBP	0.0%
2020 FY	-1.37 Million GBP	-23.79%
2019 Q4	-446 Thousand GBP	0.0%
2019 Q2	-669 Thousand GBP	0.0%
2019 FY	-1.11 Million GBP	26.15%
2018 FY	-1.5 Million GBP	-2517.63%
2018 Q4	-616 Thousand GBP	-63.35%
2018 Q3	-377.1 Thousand GBP	57.72%
2018 Q2	-892 Thousand GBP	-402.15%
2018 Q1	-177.63 Thousand GBP	-483.27%
2017 Q2	92.84 Thousand GBP	193.53%
2017 Q4	-30.45 Thousand GBP	0.0%
2017 FY	62.39 Thousand GBP	-50.69%
2017 Q1	31.63 Thousand GBP	0.0%
2016 Q1	6921.25 GBP	0.0%
2016 FY	126.53 Thousand GBP	357.03%
2016 Q4	31.63 Thousand GBP	0.0%
2016 Q3	31.63 Thousand GBP	0.0%
2015 Q4	6921.25 GBP	0.0%
2015 Q3	6921.25 GBP	128.02%
2015 FY	27.68 Thousand GBP	128.02%
2015 Q2	-24.69 Thousand GBP	0.0%
2015 Q1	-24.69 Thousand GBP	0.0%
2014 Q4	-24.69 Thousand GBP	0.0%
2014 Q3	-24.69 Thousand GBP	0.0%
2014 FY	-98.78 Thousand GBP	17.28%
2013 FY	-119.42 Thousand GBP	74.76%
2012 FY	-473.21 Thousand GBP	0.0%

Peer Operating Income Comparison of Fusion Antibodies plc

Name	Operating Income	Operating Income Difference